Draft:Azaclorzine
Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by Citation bot (talk | contribs) 4 seconds ago. (Update) |
Clinical data | |
---|---|
Other names | Nonachlazine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H24ClN3OS |
Molar mass | 413.96 g·mol−1 |
3D model (JSmol) | |
| |
|
Phenothiazine antipsychotic. Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.[1]
Synthesis
[edit]A chemical synthesis is proposed:[2][3][4] Patent:[5]
From above it is seen that Hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one [16620-61-4] (1) is the starting material. Reduction of the amide to Octahydropyrrolo[1,2-a]pyrazine (aka 1,4-Diazabicyclo[4.3.0]nonane) (2) [5654-83-1]. Using convergence synthetic methodology, this is used to displace the halogen in 3-Chloro-1-(2-Chloro-Phenothiazin-10-yl)-Propan-1-One [1032-19-5] (4) to give Azaclorzine product.
See also
[edit]- 5654-83-1 shared with Pirolazamide, BD1031, Azaftozine & Azabuperone.
References
[edit]- ^ Kaverdina NV, Markova GA (1975). "[Pharmacology of a new anti-angina preparation, nonachlazin]". Farmakologiia i Toksikologiia (in Russian). 38 (2): 173–7. PMID 1227883.
- ^ Kaverina NV, Klimova NV, Likhosherstov AM, Nazarova LS, Pidevich IN, Petukhov AG, et al. (May 1979). "Nonachlazine: A new preparation for treating ischemic heart disease". Pharmaceutical Chemistry Journal. 13 (5): 557–562. doi:10.1007/BF00778133.
- ^ Nazarova LS, Rodionov AP, Likhosherstov AM, Skoldinov AP (August 1980). "Azacycloalkanes. XXIV. Chemical and physical properties of nonachlazine". Pharmaceutical Chemistry Journal. 14 (8): 569–573. doi:10.1007/BF00765843.
- ^ Blancafort P, Castaer J (1976). "Azaclorzine". Drugs of the Future. 1 (4): 157. doi:10.1358/dof.1976.001.04.65181.
- ^ Arkadij Michajlovic Lichoserstov, 4 More », DE2210382 (1982 to Naucno-Issledovatel'skij Institut Farmakologii Akademii Medicinskich Nauk Sssr, Moskva, Su).